ABCDEFGHIJKLMNOPQRSTUVWXYZ
1
Supplementary Data 1. Clinical and molecular annotation of the SMC cohorts 1 and 2 and TMA
2
SMC_1. Samsung Medical Center (SMC) cohort 1 for global proteomic and phospho-proteomic characterization.
3
Column definitions: A=LC-MS/MS set, B=Tandem mass tag, C=Sample name, D=Sample ID for LC-MS/MS, E=Type of sample, F=Proteomic subtype (1=GPC1, 2=GPC2), G=RNA subtype (4 subtypes), H=RNA subtype (3 subtypes), I=Initial date, J=Date of death, K=Last followup data, L=Expired (dead=1), M=Overall survival period, N=Progression free survival period, O=Gender, P=Age, Q=Available longitudial pair, R=Initial or recurred sample, S=Tumor grade, T=Pathlogy, U=Temozolomide treatment, V=Radiotherapy treatment, W=Extra treatment, X=Other clinical features, Y~AN=Mutation type, AO=Tumor purity by ESTIMATE
4
SMC_2. Samsung Medical Center (SMC) cohort 2 for validation with surrogate RNA features.
5
Column definitions: A=Sample name, B=Surrogate proteomic subtype (1=sGPC1, 2=sGPC2), C=Overall survival period, D=Progression free survival period, E=Expired(dead=1), F=Available paired sample, G=IDH1 mutation status, H=Pathology
6
SMC_TMA. Samsung Medical Center (SMC) Tissue Microarray (TMA) cohort for validation with multiplex fluorescent immunohistochemistry.
7
Column definitions: A=Sample name, B=IDH mutation status, C=Tumor grade, D=Patient id, E=Cohort, F=Pathology, G=Operation date, H=Initial tumor diagnosis date, I=Deceased(dead=1), J=Insurrance expired date, K=Last follow up date, L=Overall survival period, M=Surrogate proteomic subtype, N=Nestin positive/PHGDH negative cell fraction, O=PHGDH positive/Nestin negative cell fraction.
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100